- Home
- FGEN vs MYO Comparison
FGEN vs MYO Comparison
Compare FGEN & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- MYO
- Stock Information
- Founded
- FGEN 1993
- MYO 2004
- Country
- FGEN United States
- MYO United States
- Employees
- FGEN N/A
- MYO N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- MYO Industrial Specialties
- Sector
- FGEN Health Care
- MYO Health Care
- Exchange
- FGEN Nasdaq
- MYO Nasdaq
- Market Cap
- FGEN 45.1M
- MYO 36.5M
- IPO Year
- FGEN 2014
- MYO 2017
- Fundamental
- Price
- FGEN $11.12
- MYO $0.93
- Analyst Decision
- FGEN Strong Buy
- MYO Strong Buy
- Analyst Count
- FGEN 2
- MYO 3
- Target Price
- FGEN $146.50
- MYO $7.83
- AVG Volume (30 Days)
- FGEN 24.8K
- MYO 2.1M
- Earning Date
- FGEN 11-03-2025
- MYO 11-07-2025
- Dividend Yield
- FGEN N/A
- MYO N/A
- EPS Growth
- FGEN N/A
- MYO N/A
- EPS
- FGEN N/A
- MYO N/A
- Revenue
- FGEN $7,346,000.00
- MYO $40,760,091.00
- Revenue This Year
- FGEN N/A
- MYO $24.69
- Revenue Next Year
- FGEN N/A
- MYO $20.91
- P/E Ratio
- FGEN N/A
- MYO N/A
- Revenue Growth
- FGEN N/A
- MYO 93.08
- 52 Week Low
- FGEN $4.50
- MYO $0.80
- 52 Week High
- FGEN $21.94
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- FGEN 50.35
- MYO 39.38
- Support Level
- FGEN $10.59
- MYO $1.04
- Resistance Level
- FGEN $11.22
- MYO $1.13
- Average True Range (ATR)
- FGEN 0.52
- MYO 0.08
- MACD
- FGEN -0.00
- MYO -0.01
- Stochastic Oscillator
- FGEN 58.60
- MYO 7.09
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).